참고문헌 (30)

1. G.V. Satyavati 377 1976 Medicinal plants of India, Vol. I Satyavati GV, Raina MK, Sharma M. In: Medicinal plants of India, Vol. I, Indian Council of Medical Research, New Delhi 1976; p. 377-379. 

2. Br J Exp Pathol M. Mishra 62 5 526 1981 Mishra M, Pathak UN, Khan AB. Emblica officinalis Gaertn and serum cholesterol level in experimental rabbits. Br J Exp Pathol 1981; 62(5): 526-528. 

3. J Ethnopharmacol R. Mathur 50 2 61 1996 10.1016/0378-8741(95)01308-3 Mathur R, Sharma A, Dixit VP, Varma M. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol 1996; 50(2): 61-68. 

   상세보기

4. Ind J Med Res C.P. Thakur 79 142 1984 Thakur CP, Mandal K. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits. Ind J Med Res 1984; 79: 142-146. 

5. Eur J Clin Nutr J. Annu 42 939 1988 Annu J, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr 1988; 42: 939-944. 

   상세보기

6. J Ethnopharmacol L. Anila 79 81 2002 10.1016/S0378-8741(01)00361-0 Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J Ethnopharmacol 2002; 79:81-87. 

   상세보기

7. Ind J Pharm Sci B. Antony 68 4 437 2006 10.4103/0250-474X.27814 Antony B, Merina B, Sheeba V, Mukkadan J. Effect of standardized Amla extract on atherosclerosis and dyslipidemia. Ind J Pharm Sci 2006; 68(4): 437-441. 

   

8. Phytomedicine S.K. Bhattacharya 9 171 2002 10.1078/0944-7113-00090 Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart. Phytomedicine 2002; 9:171-174. 

   상세보기

9. Ind J Chem S. Ghosal 35B 941 1996 Ghosal S, Tripathi VK, Chauhan S. Active constituents of Emblica officinalis: Part I-The chemistry and anti-oxidative effects of two new hydrolysable tannins, Emblicanin A and B. Ind J Chem 1996; 35(B): 941-948. 

10. Ind J Exp Biol M. Tariq 15 485 1977 Tariq M, Hussain SJ, Asif M, Jahan M. Protective effect of fruit extracts of Emblica officinalis (Gaertn) and Terminalia belerica (Roxb.) in experimental myocardial necrosis in rats. Ind J Exp Biol 1977; 15:485-486. 

11. A composition to enhance HDL cholesterol, reduce inflammation and hyperglycemia and correct dysthyroidism in humans, and a method for its preparation. (Patent under processing) 

12. Ind J Nat Prod B. Antony 23 2 14 2007 Antony B, Merina B, Sheeba V. Toxicity Studies of Amlamax™ - Purified Standardized Extract of Emblica Officinalis. Ind J Nat Prod 2007; 23(2):14-17. 

13. Heart Disease and Stroke Statistics - 2006 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 2006, e85-e129; available from http://www.circulationaha.org 

14. Arch Intern Med R.J. Goldberg 167 1766 2007 10.1001/archinte.167.16.1766 Goldberg RJ, Spencer FA, Steg PG, Flather M, Montalescot G, Gurfinkel EP, et al. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century. Arch Intern Med 2007; 167:1766-1773. 

    상세보기

15. Science R. Ross 193 1094 1976 10.1126/science.822515 Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976; 193:1094-1100. 

    상세보기

16. Nature P. Libby 420 868 2002 10.1038/nature01323 Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874. 

    상세보기

17. J Clin Invest M.B. Pepys 111 1805 2003 10.1172/JCI200318921 Pepys MB, Hirscfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-1812. 

    상세보기

18. Circulation P.M. Ridker 97 2007 1998 10.1161/01.CIR.97.20.2007 Ridker PM, Glynn RJ, Hennekens CH. C-Reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-2011. 

    상세보기

19. Circulation W.K. Lagrand 100 96 1999 10.1161/01.CIR.100.1.96 Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. C-Reactive protein as a cardiovascular risk factor: more than an epiphenomenon? [Review]. Circulation 1999;100:96-102. 

    상세보기

20. Circulation P. Libby 100 1148 1999 10.1161/01.CIR.100.11.1148 Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice [Editorial; comment]. Circulation 1999;100:1148-1150. 

    상세보기

21. Lancet C. Kluft 353 1274 1999 10.1016/S0140-6736(05)66951-6 Kluft C, de Maat MP, Gevers Leuven JA, Potter van Loon BJ, Mohrschladt MF. Statins and C-reactive protein [Letter]. Lancet 1999;353:1274. 

    상세보기

22. Lancet T.E. Strandberg 353 118 1999 10.1016/S0140-6736(05)76154-7 Strandberg TE, Van Hanen H, Tikkanen MJ. Effect of statins on C-reactive protein in patients with coronary artery disease [Letter]. Lancet 1999;353:118-119. 

    상세보기

23. P. Roeschlau 1980 1974 Methods of Enzymatic Analysis 2nd Edn. Roeschlau P. In; Bergmeyer, H.U., Eds., Methods of Enzymatic Analysis, 2nd Edn., Academic Press, New York 1974; p. 1980. 

24. J Lipid Res M. Burstein 11 583 1970 10.1016/S0022-2275(20)42943-8 Burstein M. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-595. 

    상세보기

25. Clin Chem G. Bucolo 19 476 1973 10.1093/clinchem/19.5.476 Bucolo G, David H. Quantitative Determination of Serum Triglycerides by the Use of Enzymes. Clin Chem 1973; 19: 476-482. 

    상세보기

26. Clin Chem W.T. Frieldwald 18 499 1972 10.1093/clinchem/18.6.499 Frieldwald WT, Levi RI, Friedericksn DS. Estimation of the Concentration of Low- Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem 1972; 18: 499-502. 

    상세보기

27. Nat Med C.J. Binder 8 1218 2002 10.1038/nm1102-1218 Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherosclerosis. Nat Med 2002; 8:1218-1226. 

    상세보기

28. J Nat Prod I. Abe 64 1010 2001 10.1021/np010100y Abe I, Keshiwagi Y, Noguchi H, Tanake T, Ikeshiro Y, Kashiwada Y. Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase. J Nat Prod 2001; 64:1010-1014. 

    상세보기

29. J Lipid Res V.G. Cabana 30 39 1989 10.1016/S0022-2275(20)38390-5 Cabana VG, Siegel JN, Sabesin SM. Effects of acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30: 39-49. 

    상세보기

30. Metabolism K. Sammalkorpi 37 859 1988 10.1016/0026-0495(88)90120-5 Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37:859-865. 

    상세보기